SCHEMBL19933754

SCHEMBL19933754

CC1(C)c2cc3c(cc2-c2cc4c5ccccc5n(-c5ccc(-c6ccccc6)cc5)c4cc21)c1ccccc1n3-c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.49
▸ KDM4E B2RXH2 1/20 0.49
▸ ATM Q13315 1/20 0.49
▸ HDAC4 P56524 1/20 0.41
▸ KMT2A Q03164 2/20 0.36
▸ IL1R1 P14778 1/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ AVPR1A P37288 1/20 0.34
▸ MAPK8 P45983 1/20 0.33
▸ AKR1C4 P17516 1/20 0.33
▸ AKR1C3 P42330 1/20 0.33
▸ AKR1C2 P52895 1/20 0.33
▸ AKR1C1 Q04828 1/20 0.33
▸ TSPO P30536 1/20 0.33
▸ GSK3B P49841 1/20 0.33
▸ RXRA P19793 1/20 0.33
▸ RXRB P28702 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14822257 0.99 L3MBTL1 (0.50) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL802598 0.99 L3MBTL1 (0.46) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL19933753 0.95 L3MBTL1 (0.44) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL14822438 0.94 KDM4E (0.55) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL14822445 0.94 L3MBTL1 (0.43) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL15946320 0.94 L3MBTL1 (0.43) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL782525 0.94 L3MBTL1 (0.41) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL802130 0.93 KDM4E (0.56) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL15337988 0.93 L3MBTL1 (0.42) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL14849853 0.92 L3MBTL1 (0.44) L3MBTL1KDM4EATMHDAC4KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917903-B2 Metal complexes UDC IRELAND LIMITED (IE) 2024-02-27 — — US disclosed
US-11917903-B2 Metal complexes UDC IRELAND LIMITED (IE) 2024-02-27 — — US disclosed
US-20230320191-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2023-10-05 — — US disclosed
US-20230320191-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2023-10-05 — — US disclosed
US-11659763-B2 Metal complexes MERCK PATENT GMBH 2023-05-23 — — US disclosed
US-11659763-B2 Metal complexes MERCK PATENT GMBH 2023-05-23 — — US disclosed
EP-3752512-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2023-03-01 — — EP disclosed
US-11569458-B2 Metal complexes MERCK PATENT GMBH (DE) 2023-01-31 — — US disclosed
US-11535640-B2 Metal complexes MERCK PATENT GMBH (DE) 2022-12-27 — — US disclosed
US-11322696-B2 Metal complexes MERCK PATENT GMBH (DE) 2022-05-03 — — US disclosed
US-20200052213-A1 BINUCLEAR METAL COMPLEXES AND ELECTRONIC DEVICES, IN PARTICULAR ORGANIC ELECTROLUMINESCENT DEVICES CONTAINING SAID METAL COMPLEXES MERCK PATENT GMBH (DE) 2020-02-13 — — US disclosed
US-20190292210-A1 BINUCLEAR METAL COMPLEXES FOR USE AS EMITTERS IN ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2019-09-26 — — US disclosed
WO-2019158453-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2019-08-22 — — WO disclosed
US-20190252628-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2019-08-15 — — US disclosed
US-20190202851-A1 BINUCLEAR AND TRINUCLEAR METAL COMPLEXES COMPOSED OF TWO INTER-LINKED TRIPODAL HEXADENTATE LIGANDS FOR USE IN ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2019-07-04 — — US disclosed
WO-2019115423-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2019-06-20 — — WO disclosed
WO-2019020538-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2019-01-31 — — WO disclosed
WO-2018069196-A1 BINUCLEAR METAL COMPLEXES AND ELECTRONIC DEVICES, IN PARTICULAR ORGANIC ELECTROLUMINESCENT DEVICES CONTAINING SAID METAL COMPLEXES MERCK PATENT GMBH (DE) 2018-04-19 — — WO disclosed
WO-2018069273-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2018-04-19 — — WO disclosed
WO-2018041769-A1 BINUCLEAR AND TRINUCLEAR METAL COMPLEXES COMPOSED OF TWO INTER-LINKED TRIPODAL HEXADENTATE LIGANDS FOR USE IN ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2018-03-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190202851-A1 BINUCLEAR AND TRINUCLEAR METAL COMPLEXES COMPOSED OF TWO INTER-LINKED TRIPODAL HEXADENTATE LIGANDS FOR USE IN ELECTROLUMINESCENT DEVICES PARN, PUF60, PARG L3MBTL1 1520/4885KDM4E 4048/4885ATM 3697/4885
US-20190252628-A1 METAL COMPLEXES AP1M1, AP2M1, AP3M1 L3MBTL1 3031/4885KDM4E 3877/4885ATM 4131/4885
US-20190292210-A1 BINUCLEAR METAL COMPLEXES FOR USE AS EMITTERS IN ORGANIC ELECTROLUMINESCENT DEVICES AP2M1, MCU, AP3M1 L3MBTL1 2504/4885KDM4E 4613/4885ATM 4246/4885
US-20230320191-A1 METAL COMPLEXES IMMT, MCU, SOD1 L3MBTL1 3259/4885KDM4E 4470/4885ATM 4048/4885
US-11322696-B2 Metal complexes AP1M1, AP3M1, AP2M1 L3MBTL1 3543/4885KDM4E 4376/4885ATM 4372/4885
US-11535640-B2 Metal complexes IMMT, MCU, SOD1 L3MBTL1 3259/4885KDM4E 4470/4885ATM 4048/4885
US-11659763-B2 Metal complexes IMMT, MCU, SOD1 L3MBTL1 3259/4885KDM4E 4470/4885ATM 4048/4885
US-11569458-B2 Metal complexes IMMT, MCU, SOD1 L3MBTL1 3259/4885KDM4E 4470/4885ATM 4048/4885
US-20200052213-A1 BINUCLEAR METAL COMPLEXES AND ELECTRONIC DEVICES, IN PARTICULAR ORGANIC ELECTROLUMINESCENT DEVICES CONTAINING SAID METAL COMPLEXES BICRA, NCLN, IMMT L3MBTL1 3344/4885KDM4E 3160/4885ATM 4082/4885
US-11917903-B2 Metal complexes NCLN, BICRA, AP3M1 L3MBTL1 2532/4885KDM4E 3870/4885ATM 3416/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback